Skip to main content
. 2020 Oct 15;16(10):1745–1751. doi: 10.5664/jcsm.8692

Table 3.

Subgroup analysis in participants with and without unpleasant symptoms during menses.

M1 M2 MF P for Interaction
TIB, min Yes (n = 31) 404.7 ± 69.0 358.6 ± 78.3 391.3 ± 78.9 .150
No (n = 14) 383.8 ± 41.7 378.9 ± 53.0 413.4 ± 61.4
TST, min Yes (n = 31) 361.5 ± 68.2 321.7 ± 75.4 362.9 ± 74.1 .136
No (n = 14) 346.8 ± 46.2 352.6 ± 50.9 382.4 ± 57.6
SOL, min Yes (n = 31) 14.5 (15.8) 16.5 (19.3) 9.0 (9.8) .221
No (n = 14) 15.0 (24.5) 11.5 (18.0) 14.5 (23.0)
SE, % Yes (n = 31) 89.4 ± 7.7 89.9 ± 7.3 93.4 ± 5.3 .332
No (n = 14) 90.5 ± 8.9 93.1 ± 4.1 92.7 ± 5.5
WASO, min Yes (n = 31) 10.0 (12.5) 8.0 (10.3) 7.0 (7.9) .585
No (n = 14) 7.5 (10.0) 10.3 (12.0) 6.3 (8.0)
% of REM sleep, % Yes (n = 31) 27.9 ± 6.2 25.7 ± 5.5 27.0 ± 4.5 .084
No (n = 14) 24.2 ± 7.1 25.6 ± 6.9 27.9 ± 3.4
% of N3 sleep, % Yes (n = 31) 22.1 ± 8.9 23.5 ± 6.6 24.8 ± 6.7 .038
No (n = 14) 28.8 ± 7.8 27.0 ± 10.7 24.2 ± 6.3
Ar I, events/h of sleep Yes (n = 31) 7.7 ± 2.7 7.1 ± 2.5 7.0 ± 1.8 .865
No (n = 14) 6.7 ± 2.9 5.7 ± 2.3 6.0 ± 3.2

Continuous data are summarized using the mean ± standard deviation or median (interquartile range). ArI = arousal index, M1/2 = first and second night after menses onset, MF = midfollicular phase, N3 = deep non-REM sleep, REM = rapid eye movement, SE = sleep efficiency, SOL = sleep onset latency, TST = total sleep time, WASO = wake after sleep onset.

HHS Vulnerability Disclosure